BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38715375)

  • 1. Saponin monomers: Potential candidates for the treatment of type 2 diabetes mellitus and its complications.
    Zhang L; He S; Liu L; Huang J
    Phytother Res; 2024 May; ():. PubMed ID: 38715375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Contents of total anthocyanins and total saponins as well as composition of saponin monomers of Purple and Green Notoginseng Radix et Rhizoma].
    Zhao CL; Yang SC; Chen ZJ; Shen Y; Wei FG; Wang W; Long TJ
    Zhong Yao Cai; 2014 Oct; 37(10):1749-53. PubMed ID: 25895378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into anti-diabetes effects and molecular mechanisms of dietary saponins.
    Zhou Y; Xu B
    Crit Rev Food Sci Nutr; 2023 Nov; 63(33):12372-12397. PubMed ID: 35866515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Rb1 protects against diabetes-associated metabolic disorders in Kkay mice by reshaping gut microbiota and fecal metabolic profiles.
    Zhou R; He D; Zhang H; Xie J; Zhang S; Tian X; Zeng H; Qin Y; Huang L
    J Ethnopharmacol; 2023 Mar; 303():115997. PubMed ID: 36509256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Potential of Ginsenosides as an Adjuvant Treatment for Diabetes.
    Bai L; Gao J; Wei F; Zhao J; Wang D; Wei J
    Front Pharmacol; 2018; 9():423. PubMed ID: 29765322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactive Agent Discovery from the Natural Compounds for the Treatment of Type 2 Diabetes Rat Model.
    Yang SC; Hsu CY; Chou WL; Fang JY; Chuang SY
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33287318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Possible Role of Saponin in Type-II Diabetes- A Review.
    Choudhary N; Khatik GL; Suttee A
    Curr Diabetes Rev; 2021; 17(2):107-121. PubMed ID: 32416696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragaloside IV alleviates liver injury in type 2 diabetes due to promotion of AMPK/mTOR‑mediated autophagy.
    Zhu Y; Su Y; Zhang J; Zhang Y; Li Y; Han Y; Dong X; Li W; Li W
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herbal Medicines for Diabetes Management and its Secondary Complications.
    Kumar S; Mittal A; Babu D; Mittal A
    Curr Diabetes Rev; 2021; 17(4):437-456. PubMed ID: 33143632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis.
    Zhou P; Xie W; He S; Sun Y; Meng X; Sun G; Sun X
    Cells; 2019 Feb; 8(3):. PubMed ID: 30823412
    [No Abstract]   [Full Text] [Related]  

  • 12. Endoplasmic reticulum as a therapeutic target in type 2 diabetes: Role of phytochemicals.
    Sajadimajd S; Deravi N; Forouhar K; Rahimi R; Kheirandish A; Bahramsoltani R
    Int Immunopharmacol; 2023 Jan; 114():109508. PubMed ID: 36495694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.
    Huang XP; Ding H; Lu JD; Tang YH; Deng BX; Deng CQ
    Am J Chin Med; 2015; 43(7):1419-38. PubMed ID: 26477799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protective effects of flavonoids and carotenoids against diabetic complications-A review of
    Jin Y; Arroo R
    Front Nutr; 2023; 10():1020950. PubMed ID: 37032781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycyrrhizic Acid and Its Derivatives: Promising Candidates for the Management of Type 2 Diabetes Mellitus and Its Complications.
    Tan D; Tseng HHL; Zhong Z; Wang S; Vong CT; Wang Y
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactive Compounds in Anti-Diabetic Plants: From Herbal Medicine to Modern Drug Discovery.
    Tran N; Pham B; Le L
    Biology (Basel); 2020 Aug; 9(9):. PubMed ID: 32872226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginsenoside Rg1 attenuates glomerular fibrosis by inhibiting CD36/TRPC6/NFAT2 signaling in type 2 diabetes mellitus mice.
    Han Y; Su Y; Han M; Liu Y; Shi Q; Li X; Wang P; Li W; Li W
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115923. PubMed ID: 36375645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UHPLC-MS-Based Serum and Urine Metabolomics Reveals the Anti-Diabetic Mechanism of Ginsenoside Re in Type 2 Diabetic Rats.
    Wang H; Teng Y; Li S; Li Y; Li H; Jiao L; Wu W
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771066
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of diosgenin in diabetes and diabetic complications.
    Gan Q; Wang J; Hu J; Lou G; Xiong H; Peng C; Zheng S; Huang Q
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105575. PubMed ID: 31899316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Rg1 promotes glucose uptake through activated AMPK pathway in insulin-resistant muscle cells.
    Lee HM; Lee OH; Kim KJ; Lee BY
    Phytother Res; 2012 Jul; 26(7):1017-22. PubMed ID: 22170817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.